What information leads you to believe that? The board members, including a 42 year senator, president/CEO of one of the largest financial institutions, a C-level executive in Pfizer. Is it the fact that their publications are actually being reviewed with the scientific community and you see fault in the results? Is it the continued SEC filings and meeting of requirements for Nasdaq uplist?
This stock will be at $500 on Monday, and $3 on Tuesday. I can make baseless claims all day too.